Trump, while on a campaign swing to Nevada, tweeted that he'd signed an order on the "most favored nation" plan, which would try to link Medicare Part B and Part D prices to lower prices paid by other countries. The approach was broader than an initial effort that only targeted Part B.
The order is a first step that instructs the U.S. Department of Health and Human Services to begin the rule-making process to test "a payment model" for some medicines. It offered few details.
alJazeera
Because they know it's not going to happen. It was something for him to campaign on. That's it.
"The cost of prescription drugs will be dropping like a rock very soon," Trump said Sunday at a rally in Henderson, Nevada. "The drug companies don't like me too much."
They're not the only ones.
The order falls far short of an immediate cut that Trump has touted would lower patients' out-of-pocket costs. Instead, it starts the process for HHS Secretary Alex Azar to test the impact of such a change. That likely means patients won't see lower prices until well after the U.S. presidential election in November, if at all, as the path to lowering drug prices remains uncertain.
...but hey, do what you want...you will anyway.
No comments:
Post a Comment